Dithranol in a cream preparation: Disperse or dissolve?

Skin Pharmacology and Applied Skin Physiology

Volumn 13, Issue 5, 2000, Pages 273-279

  Prins, M ^b   Swinkels, O Q J ^c   Bouwhuis, S ^c   De Gast, M J ^c   Bouwman Boer, Y ^a   Van Der Valk, P G M ^c   Van De Kerkhof, P C M ^c  

^a Inspectorate for Health Care   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

Cream preparation; Disperse; Dissolve; Dithranol; Psoriasis; Short contact treatment

Indexed keywords

DITHRANOL;

ARTICLE; CREAM; DISPERSION; DISSOLUTION; DRUG EFFICACY; DRUG FORMULATION; PRIORITY JOURNAL; PSORIASIS; RELIABILITY; SKIN IRRITATION;

EID: 0033844459     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029933     Document Type: Article

References (16)

1. van de Kerkhof PCM: Dithranol treatment for psoriasis: After 75 years, still going strong! Eur J Dermatol 1991;1:79-88.
2. Schaefer H, Farber EM, Goldberg L, Schalla W: Limited application period for dithranol in psoriasis. Br J Derm 1980;102:571-573.
3. Green PG, Kennedy CTC, Forbes DR: Anthralin stability in various vehicles. J Am Acad Dermatol 1987; 16:984-988.
4. Kneckze M, Rahm C, Landersjo L, Lundgren P: In vitro release of anthralin from white petrolatum and an o/w cream. Acta Pharm Nord 1989;1(5):249-257.
5. Kneckze M, Rahm C, Landersjo L, Lundgren P: The influence of salicylic acid on the in vitro release of anthralin from an o/w cream. Acta Pharm Nord 1990;2(5):313-318.
6. Ros JJW, van der Meer YG, De Hoop D, De Kort WJA, van Andel P: In vitro and in vivo comparison of creams containing dithranol 0.5%. Pharm Weekbl Sci 1991; 13(5):210-214.
7. Ros JJW, van der Meer YG: Preparation, analysis and stability of oil-in-water creams containing dithranol. Eur J Hosp Pharm 1991;1(3): 77-84.
8. Prins M, Swinkels OQJ, Snater E, Metsers HC, Gerritsen MJP, van de Kerkhof PCM, van der Valk PGM: Gecombineerde dag- en thuisbehandeling van psoriasis met kortcontact-dithranolapplicaties. NTv-DV 1997;7:1-4.
9. Fredenksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978; 157:238-242.
10. Ramsay B, Lawrence CM: Measurement of involved surface area in patients with psoriasis. Br J Dermatol 1991;124:235-240.
11. Wiechers JW: The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekbl Sci 1989;11(6):185-198.
12. Prins M, Swinkels OQJ, Kolkman EGW, Wuis EW, Hekster YA, van der Valk PGM: Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation. Acta Derm Venereol (Stockh) 1998;78:262-265.
13. Volden G, Bjornberg A, Tegner E, Pedersen NB, Aries UB, Agren S, Brolund L: Short-contact treatment at home with Micanol. Acta Derm Venercol Suppl (Stockh) 1992;172: 20-22.
14. Christensen OB, Enstrom Y, Juhlin L, Reidhav I, Svensson A, Bjellerup M, Ridderstrom E, Larsson-Stymne B, Brolund L: A novel dithranol formulation in the overnight treatment of psoriasis at home. Acta Derm Venereol Suppl (Stockh) 1992;172: 25-27.
15. Miller AC: Anthralin cream as short-contact therapy for psoriasis. Cutis 1985;35(6):578-582.
16. Grattan CEH, Christopher AP, Robinson M: A paired comparison of cream and ointment-based dithranol in short-contact treatment of psoriasis. Br J Dermatol 1987;116: 279-280.